These data are further supported by the PyMT-MMTV genetic studies by Li et al. (68), which demonstrated that Pthlh ablation reduces primary breast tumor growth with reductions in pro-proliferative factors Ki67 and cyclin D1 as well as the anti-apoptotic protein Bcl-2, all factors known to regulate dormancy. This evidence concerns the gene PTHLH and breast neoplasm.